Latest Glenmark Pharmaceuticals stock price
Glenmark Pharmaceuticals P/E Ratio
GLENMARK • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
57.98
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
57.98
Current Price
₹2079.80
EPS (TTM)
₹37.11
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
20.09
Historical Range
10.2 - 29.84
Percentile
100.0%
Sector Context
Sector Average
57.32
Sector Median
35.38
Sector Rank
#11 of 88
Sector Percentile
12.5%
Earnings Breakdown (TTM)
TTM EPS
₹36.00
Sept 2025
₹21.63
Mar 2025
₹0.16
Key P/E Ratio Insights for Glenmark Pharmaceuticals
- Stock appears overvalued with PE of 57.98, suggesting caution for new investments
- Current PE is 188.7% above historical average
View the GLENMARK equity price for detailed stock performance.
P/E Ratio Historical Trend for Glenmark Pharmaceuticals
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Glenmark Pharmaceuticals
Additional stock information and data for GLENMARK
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2022 | 16.82 | 31.22 | ₹525.25 | NSE | Moderate |
| 2021 | 13.91 | 36.14 | ₹502.60 | NSE | Low |
| 2020 | 10.2 | 33.9 | ₹345.70 | NSE | Low |
| 2019 | 27.23 | 25.42 | ₹692.15 | NSE | High |
| 2018 | 18.39 | 32.42 | ₹596.10 | NSE | Moderate |
| 2017 | 29.84 | 29.62 | ₹884.00 | NSE | High |
| 2016 | 24.21 | 38.15 | ₹923.75 | NSE | Moderate |
Sector P/E Ratio Comparison
Comparing Glenmark Pharmaceuticals with other companies in Healthcare sector
Sector Average
57.32
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |